These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21561876)

  • 1. Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention.
    Hedin CR; Stagg AJ; Whelan K; Lindsay JO
    Gut; 2012 Feb; 61(2):311-8. PubMed ID: 21561876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease.
    D'Incà R; Annese V; di Leo V; Latiano A; Quaino V; Abazia C; Vettorato MG; Sturniolo GC
    Aliment Pharmacol Ther; 2006 May; 23(10):1455-61. PubMed ID: 16669960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of postoperative recurrence in Crohn's disease.
    Ahmed T; Rieder F; Fiocchi C; Achkar JP
    Gut; 2011 Apr; 60(4):553-62. PubMed ID: 21115545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy.
    Fries W; Renda MC; Lo Presti MA; Raso A; Orlando A; Oliva L; Giofré MR; Maggio A; Mattaliano A; Macaluso A; Cottone M
    Am J Gastroenterol; 2005 Dec; 100(12):2730-6. PubMed ID: 16393227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered intestinal microbiota and blood T cell phenotype are shared by patients with Crohn's disease and their unaffected siblings.
    Hedin CR; McCarthy NE; Louis P; Farquharson FM; McCartney S; Taylor K; Prescott NJ; Murrells T; Stagg AJ; Whelan K; Lindsay JO
    Gut; 2014 Oct; 63(10):1578-86. PubMed ID: 24398881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility loci reported in genome-wide association studies are associated with Crohn's disease in Canadian children.
    Amre DK; Mack DR; Morgan K; Israel D; Deslandres C; Seidman EG; Lambrette P; Costea I; Krupoves A; Fegury H; Dong J; Grimard G; Levy E
    Aliment Pharmacol Ther; 2010 Jun; 31(11):1186-91. PubMed ID: 20222910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide association studies and Crohn's disease.
    Lee JC; Parkes M
    Brief Funct Genomics; 2011 Mar; 10(2):71-6. PubMed ID: 21436303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular stratification of Crohn's disease by chemokine receptors: fractalkine receptor polymorphisms define a fibrostenosing ileal subgroup.
    Binion DG; Kugathasan S; Dwinell MB
    Am J Gastroenterol; 2006 Jan; 101(1):107-9. PubMed ID: 16405541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of human leucocyte DR and DQ antigens in Crohn's disease in Asian Indians: a family study.
    Thakur S; Ranjan P; Ghoshal UC; Muller-Myhsok B; Khan F; Talwar S; Agarwal S
    Trop Gastroenterol; 2003; 24(4):185-8. PubMed ID: 15164528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in Crohn's disease: the reverse side of the medal.
    Dessein R; Chamaillard M; Danese S
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S144-7. PubMed ID: 18806708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new look at Crohn's disease: breakdown of the mucosal antibacterial defense.
    Wehkamp J; Stange EF
    Ann N Y Acad Sci; 2006 Aug; 1072():321-31. PubMed ID: 17057212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of gut microbiota in Crohn's disease.
    Baker PI; Love DR; Ferguson LR
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):535-46. PubMed ID: 19817674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
    Lee SH; Turpin W; Espin-Garcia O; Raygoza Garay JA; Smith MI; Leibovitzh H; Goethel A; Turner D; Mack D; Deslandres C; Cino M; Aumais G; Panaccione R; Jacobson K; Bitton A; Steinhart AH; Huynh HQ; Princen F; Moayyedi P; Griffiths AM; Silverberg MS; Paterson AD; Xu W; Croitoru K;
    Gastroenterology; 2021 Nov; 161(5):1540-1551. PubMed ID: 34293299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on genetics in inflammatory disease.
    Noomen CG; Hommes DW; Fidder HH
    Best Pract Res Clin Gastroenterol; 2009; 23(2):233-43. PubMed ID: 19414149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
    Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
    Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of 3p21 with Crohn's disease in a New Zealand population.
    Morgan AR; Han DY; Lam WJ; Fraser AG; Ferguson LR
    Hum Immunol; 2010 Jun; 71(6):602-9. PubMed ID: 20307617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.